122PICOTINIB AS FIRST-LINE TREATMENT FOR ELDERLY PATIENTS WITH EGFR 19 OR 21 MUTATION IN ADVANCED NSCLC: A PHASE-IV, OPEN-LABEL, SINGLE-ARM STUDY


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles